Oramed Pharmaceuticals Inc.
ORMP · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 8/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $54 | $9 | $40 | $77 |
| Short-Term Investments | $88 | $153 | $115 | $17 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $1 | $1 |
| Total Curr. Assets | $143 | $163 | $157 | $95 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $1 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $11 | $56 | $3 | $7 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $25 |
| Total NC Assets | $12 | $58 | $5 | $33 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $155 | $221 | $162 | $128 |
| Liabilities | – | – | – | – |
| Payables | $1 | $1 | $2 | $3 |
| Short-Term Debt | $0 | $51 | $0 | $0 |
| Tax Payable | $3 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $1 | $3 |
| Other Curr. Liab. | $1 | $1 | -$0 | -$1 |
| Total Curr. Liab. | $6 | $53 | $6 | $7 |
| LT Debt | $0 | $0 | $1 | $0 |
| Deferred Rev, NC | $4 | $4 | $4 | $4 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $4 | $5 | $5 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $1 | $0 | $0 |
| Total Liabilities | $10 | $58 | $10 | $11 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$177 | -$158 | -$163 | -$115 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $645 | $321 | $314 | $230 |
| Total Equity | $146 | $164 | $152 | $116 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$1 | -$1 | -$1 | $1 |
| Total Liab. & Tot. Equity | $155 | $221 | $162 | $128 |
| Net Debt | -$54 | $43 | -$40 | -$77 |